Eric Richman - May 19, 2022 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ /s/ Eric I Richman
Stock symbol: GANX
Transactions as of: May 19, 2022
Transactions value $: $37,034
Form type: 4
Date filed: 5/23/2022, 04:41 PM
Previous filing: Mar 7, 2022
Next filing: May 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GANX	Common stock	Purchase	$10.8K	+4K	+1.98%	$2.71	206K	May 19, 2022	Direct
transaction	GANX	Common Stock	Purchase	$26.2K	+9.26K	+4.49%	$2.83	215K	May 20, 2022	Direct	F1
holding	GANX	Common Stock						14.8K	May 19, 2022	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.97 inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownershipof the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.97 inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownershipof the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.